Cardiovascular Risk Prediction Models and Scores in the Era of Personalized Medicine

Sex-Specific Added Value of Cardiac Biomarkers for 10-Year Cardiovascular Risk Prediction

(2022) Fang Zhu et al.   European Journal of Preventive Cardiology

Prognostic Value of a Polygenic Risk Score for Coronary Heart Disease in Individuals Aged 70 Years and Older

(2021) Johannes T. Neumann et al.   Circulation-Genomic and Precision Medicine

Predictive Accuracy of a Polygenic Risk Score–Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease

(2020) Joshua Elliott et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Validation of the Systematic COronary Risk Evaluation - Older Persons (SCORE-OP) in the EPIC-Norfolk prospective population study

(2019) Lotte Verweij et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

The Accuracy of Cardiovascular Pooled Cohort Risk Estimates in U.S. Older Adults

(2019) Michael G. Nanna et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Comparisons of the Framingham and Pooled Cohort Equation Risk Scores for Detecting Subclinical Vascular Disease in Blacks Versus Whites

(2018) Matthew L. Topel et al.   AMERICAN JOURNAL OF CARDIOLOGY

Sex differences in impact of coronary artery calcification to predict coronary artery disease

(2018) Yoko M Nakao et al.   HEART

Temporal trends in cardiovascular risk factors and performance of the Framingham Risk Score and the Pooled Cohort Equations

(2018) Susanne Rospleszcz et al.   JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH

Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women’s Health Initiative

(2018) Samia Mora et al.   JAMA Internal Medicine

2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension

(2018) Bryan Williams et al.   JOURNAL OF HYPERTENSION

Prediction of atherosclerotic cardiovascular disease mortality in a nationally representative cohort using a set of risk factors from pooled cohort risk equations

(2017) Zefeng Zhang et al.   PLoS One

Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study

(2017) Julia Hippisley-Cox et al.   BMJ-British Medical Journal

Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study

(2017) Julia Hippisley-Cox et al.   BMJ-British Medical Journal

External Validation of Pooled Cohort Risk Equations to Predict 1-Year Clinical Outcome in Ischemic Stroke Patients

(2017) Haiyan Li et al.   MEDICAL SCIENCE MONITOR

The relationship between blood pressure variability and Pooled Cohort Risk Assessment Equations 10-year cardiovascular risk score

(2016) Murat Celik et al.   BLOOD PRESSURE MONITORING

Limitations of the SCORE-guided European guidelines on cardiovascular disease prevention

(2016) Martin Bødtker Mortensen et al.   EUROPEAN HEART JOURNAL

Migraine and risk of cardiovascular disease in women: prospective cohort study

(2016) Tobias Kurth et al.   BMJ-British Medical Journal

Migraine and risk of cardiovascular disease in women: prospective cohort study

(2016) Tobias Kurth et al.   BMJ-British Medical Journal

Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis

(2016) Peter Willeit et al.   Lancet Diabetes & Endocrinology

An Analysis of Calibration and Discrimination Among Multiple Cardiovascular Risk Scores in a Modern Multiethnic Cohort

(2015) Andrew P. DeFilippis et al.   ANNALS OF INTERNAL MEDICINE

Cardiovascular disease in Europe — epidemiological update 2015

(2015) Nick Townsend et al.   EUROPEAN HEART JOURNAL

Validation of the Atherosclerotic Cardiovascular Disease Pooled Cohort Risk Equations

(2014) Paul Muntner et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Implications of the 2013 ACC/AHA Cholesterol Guidelines for Adults in Contemporary Cardiovascular Practice

(2014) Thomas M. Maddox et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

(2013) David C. Goff et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Statins: new American guidelines for prevention of cardiovascular disease

(2013) Paul M Ridker et al.   LANCET

Evaluation of Framingham and Systematic Coronary Risk Evaluation Scores by Coronary Computed Tomographic Angiography in Asymptomatic Adults

(2012) Sonya Schneer et al.   AMERICAN JOURNAL OF CARDIOLOGY

Common Carotid Intima-Media Thickness Measurements in Cardiovascular Risk Prediction

(2012) Hester M. Den Ruijter et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Comparison of Novel Risk Markers for Improvement in Cardiovascular Risk Assessment in Intermediate-Risk Individuals

(2012) Joseph Yeboah et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Erectile dysfunction

(2012) Rany Shamloul et al.   LANCET

C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2

(2012) G. S. Collins et al.   BMJ-British Medical Journal

Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review

(2011) Sanne A E Peters et al.   HEART

A Comparative Assessment of Non-Laboratory-Based versus Commonly Used Laboratory-Based Cardiovascular Disease Risk Scores in the NHANES III Population

(2011) Ankur Pandya et al.   PLoS One

Performance of the ASSIGN cardiovascular disease risk score on a UK cohort of patients from general practice

(2010) B. de la Iglesia et al.   HEART

Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension

(2010) Peter M Rothwell et al.   LANCET

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET

Performance of the Framingham and SCORE cardiovascular risk prediction functions in a non-diabetic population of a Spanish health care centre: a validation study

(2010) Lourdes Cañón Barroso et al.   SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE

Predicting the 30-Year Risk of Cardiovascular Disease

(2009) Michael J. Pencina et al.   CIRCULATION

Prediction of Coronary Heart Disease Risk in a General, Pre-Diabetic, and Diabetic Population During 10 Years of Follow-up: Accuracy of the Framingham, SCORE, and UKPDS Risk Functions: The Hoorn Study

(2009) A. A.W.A. van der Heijden et al.   DIABETES CARE

Risk prediction is improved by adding markers of subclinical organ damage to SCORE

(2009) T. Sehestedt et al.   EUROPEAN HEART JOURNAL

Risk stratification with the risk chart from the European Society of Hypertension compared with SCORE in the general population

(2009) Thomas Sehestedt et al.   JOURNAL OF HYPERTENSION

C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction

(2008) Paul M Ridker et al.   CIRCULATION

General Cardiovascular Risk Profile for Use in Primary Care

(2008) Ralph B. D’Agostino et al.   CIRCULATION

Estimation of cardiovascular risk: a comparison between the Framingham and the SCORE model in people under 60 years of age

(2008) Tjarda Scheltens et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Ankle Brachial Index Combined With Framingham Risk Score to Predict Cardiovascular Events and Mortality

(2008)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION